Keros Therapeutics
KROS
#6688
Rank
โ‚น60.01 B
Marketcap
โ‚น1,970
Share price
0.85%
Change (1 day)
-65.34%
Change (1 year)

Revenue for Keros Therapeutics (KROS)

Revenue in 2025 (TTM): โ‚น21.14 Billion

According to Keros Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น22.21 Billion. In 2024 the company made a revenue of โ‚น0.30 Billion an increase over the revenue in the year 2023 that were of โ‚น12.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Keros Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น21.14 B6841.58%
2024 โ‚น0.30 B2322.66%
2023 โ‚น12.57 M
2022 N/A-100%
2021 โ‚น1.49 B
2020 N/A-100%
2019 โ‚น0.71 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA